What is Postural Orthostatic Tachycardia Syndrome (POTS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Postural Orthostatic Tachycardia Syndrome (POTS)

Postural Orthostatic Tachycardia Syndrome (POTS) is a clinical syndrome characterized by a sustained heart rate increase of ≥30 bpm (or ≥40 bpm in those 12-19 years old) within 10 minutes of standing, absence of orthostatic hypotension, and frequent symptoms of orthostatic intolerance that persist for at least 3 months. 1

Diagnostic Criteria

POTS is diagnosed based on the following specific criteria:

  1. Heart rate increase:

    • ≥30 bpm increase within 10 minutes of standing in adults
    • ≥40 bpm increase in adolescents aged 12-19 years 2, 1
  2. Blood pressure response:

    • Absence of orthostatic hypotension (no sustained systolic blood pressure drop of ≥20 mm Hg) 2
  3. Symptom profile:

    • Frequent symptoms of orthostatic intolerance during standing with improvement upon returning to supine position
    • Common symptoms include lightheadedness, palpitations, tremulousness, generalized weakness, blurred vision, and fatigue 2, 1
  4. Duration:

    • Symptoms present for at least 3 months 2
  5. Exclusion criteria:

    • Absence of other conditions explaining sinus tachycardia such as:
      • Anorexia nervosa
      • Primary anxiety disorders
      • Hyperventilation
      • Anemia
      • Fever, pain, infection
      • Dehydration
      • Hyperthyroidism
      • Pheochromocytoma
      • Use of cardioactive drugs
      • Severe deconditioning from prolonged bed rest 2

Pathophysiology

POTS is heterogeneous with three primary phenotypes identified:

  1. Hyperadrenergic POTS:

    • Characterized by excessive norepinephrine production or impaired reuptake
    • Results in sympathetic overactivity 3
  2. Neuropathic POTS:

    • Impaired vasoconstriction during orthostatic stress
    • Often involves peripheral sympathetic denervation 3
  3. Hypovolemic POTS:

    • Associated with reduced blood volume
    • Often triggered by dehydration and physical deconditioning 3

Clinical Presentation

Patients with POTS typically present with:

  • Dizziness and lightheadedness upon standing
  • Rapid heartbeat and palpitations
  • Weakness and fatigue
  • Physical deconditioning and reduced exercise capacity
  • Headache and "brain fog" (cognitive difficulties)
  • Dyspnea
  • Gastrointestinal symptoms
  • Musculoskeletal pain 4

Common Triggers and Associations

POTS onset is often precipitated by:

  • Viral infections (including COVID-19)
  • Vaccination
  • Trauma
  • Pregnancy
  • Surgery
  • Psychosocial stress 4, 5

Post-COVID POTS

Recent evidence indicates that 2%-14% of COVID-19 survivors develop POTS, with 9%-61% experiencing POTS-like symptoms within 6-8 months of SARS-CoV-2 infection. This specific form of POTS is now recognized as part of post-acute COVID-19 syndrome (PASC POTS) 2, 5.

Management Approach

Management of POTS focuses on:

  1. Non-pharmacological interventions (first-line for all patients):

    • Increased salt intake (10-12g daily)
    • Increased fluid intake (2-3 liters daily)
    • Compression garments for lower extremities
    • Gradual, structured exercise program
    • Avoiding triggers 1, 6
  2. Pharmacological therapy (tailored to phenotype):

    • Note: No FDA-approved medications specifically for POTS 6
    • Hyperadrenergic POTS: Low-dose beta-blockers
    • Neuropathic POTS: Midodrine, pyridostigmine
    • Hypovolemic POTS: Fludrocortisone for volume expansion 3

Prognosis

Although long-term prognosis is not well-established, approximately 50% of patients spontaneously recover within 1-3 years. However, many patients experience persistent symptoms that can significantly impact quality of life 4.

Key Clinical Considerations

  • POTS predominantly affects females (≈80%) between 15-45 years old
  • Prevalence ranges from 0.2% to 1.0% in developed countries
  • Diagnostic testing should include head-up tilt test with non-invasive beat-to-beat hemodynamic monitoring
  • POTS can be mistaken for anxiety disorders or deconditioning
  • A multidisciplinary approach involving cardiology, neurology, and rehabilitation medicine often yields the best outcomes 4, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.